Evaluation of Early Warning Indicators (EWI) of HIV Drug Resistance According to the World Health Organization (WHO) in Some Treatment Centers in Kinshasa
Background: The Early Warning Indicators (EWI) of Human Immunodefi-ciency Virus (HIV) Drug Resistance measure factors found at the site level and known to be associated with the proper functioning of the program and the prevention of the emergence of R-ARV. The fact strengthening certain aspects of implementation of the program at the sites can help minimize the occurring of HIV Drug Resistance that can be prevented to improve the long-term effectiveness and sustainability of the treatment. Objective: The objective of this study was to assess the quality of the prevention of resistance of HIV Drug compared to EWI set by the World Health Organization (WHO) in the different Ambulatory Treatment Centers (ACT) in the city of Kinshasa. Methods: The present work was a retrospective survey conducted in 2015 in 7 ACTs in the 4 districts of Kinshasa in order to evaluate the EWI. Results: Seven (7) ATCs and 157 patient records were selected based on different inclusion criteria. The maintenance of first-line Antiretroviral Treatment (ART) at 12 months and the consistent delivery of ARVs were the two EWI that were respected, evaluation at 100%, for 6 ACTs. Conclusion: The caregivers and HIV-infected patients should be trained on the EWI and their monitoring to prevent the occurrence of treatment failures and that of HIV drug resistance in Kinshasa.
Cite this paper
Okonda, M. O. , Bulanda, B. , Kabasele, J. D. , Chuga, D. , Bonganya, B. I. and Kamangu, E. N. (2019). Evaluation of Early Warning Indicators (EWI) of HIV Drug Resistance According to the World Health Organization (WHO) in Some Treatment Centers in Kinshasa. Open Access Library Journal, 6, e5500. doi: http://dx.doi.org/10.4236/oalib.1105500.
Kamangu, N.E., Bulanda, I.B., Bongenia, I.B., Botomwito, T.H., Mvumbi, L.G., De Mol, P., Vaira, D., Hayette, M.P. and Kalala, L.R. (2015) Molecular Epidemiological Profile of the HIV Infection Type 1 among Patients Naive of Treatment in Kinshasa. Annals of African Medicine, 8, 2136-2141. https://doi.org/10.4236/oalib.1101564
Kamangu, N.E., Chatté, A., Susin, F., Boreux, R., Kalala, L.R., Mvumbi, L.G., De Mol, P., Vaira, D. and Hayette, M.P. (2015) Genetic Diversity and Antiretroviral Drug Resistance among Drug-Naive HIV Type 1 Infected Patients Attending Clinics in Kinshasa, Democratic Republic of Congo. Journal of HIV and AIDS, 1, 1-5.
https://doi.org/10.16966/2380-5536.101
Egger, M., May, M. and Chene (2002) Prognosis of HIV-1 Infected Patients Starting Highly Active Therapy: A Collaborative Analysis of Prospective Studies. The Lancet, 360, 119-129. https://doi.org/10.1016/S0140-6736(02)09411-4
National AIDS Program against HIV/AIDS and Sexually Transmitted Infections (PNLS), Ministry of Public Health, Democratic Republic of Congo (DRC) (2016) National Guide for the Treatment of HIV Infection with AntiRetroVirals in Adolescents and Adults.
Huguette, B. (2013) Perception of the National e HIV Support Policy by Doctors: Case of the General Provincial Hospital of Reference of Kinshasa. Dissertation Presented for Medical Degree at the Technological University Bel Campus, Kinshasa.
Fokam, J., Billong, S.C., Bissek, A.C., Kembou, E., Milenge, P., Abessouguie, I., Nkwescheu, A.S., Tsomo, Z., Aghokeng, A.F., Ngute, G.D., Ndumbe, P.M., Colizzi, V. and Elat, J.B.N. (2013) Declining Trends in Early Warning Indicators for HIV Drug Resistance in Cameroon from 2008-2010: Lessons and Challenges for Low-Resource Settings. BMC Public Health, 13, 308. http://www.biomedcentral.com/1471-2458/13/308 https://doi.org/10.1186/1471-2458-13-308
Kamangu, E.N., Bulanda, B.I., Bongenya, B.I., Kateba, E.T., Okonda, M.O., Kasongo, V.N. and Kingombe, M.A. (2019) Evaluation of the Efficacy of the Phyto-Drug Djovikas: Traditional Treatment against HIV Infection. ARC Journal of AIDS, 4, 1-4.
Kamangu, E.N., Kalala, R.L., Mvumbi, G.L., Vaira, D. and Hayette, M.P. (2017) Involvement of the Genetic Diversity of HIV-1 in the Virological Treatment Failure of First Line Antiretroviral in Kinshasa. World Journal of AIDS, 7, 23-33. https://doi.org/10.4236/wja.2017.71003
